- Home
- NHTC vs CTSO Comparison
NHTC vs CTSO Comparison
Compare NHTC & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NHTC
- CTSO
- Stock Information
- Founded
- NHTC 1988
- CTSO 1997
- Country
- NHTC United States
- CTSO United States
- Employees
- NHTC N/A
- CTSO N/A
- Industry
- NHTC Diversified Commercial Services
- CTSO Medical/Dental Instruments
- Sector
- NHTC Miscellaneous
- CTSO Health Care
- Exchange
- NHTC Nasdaq
- CTSO Nasdaq
- Market Cap
- NHTC 55.8M
- CTSO 52.6M
- IPO Year
- NHTC 1995
- CTSO N/A
- Fundamental
- Price
- NHTC $4.51
- CTSO $1.07
- Analyst Decision
- NHTC
- CTSO Buy
- Analyst Count
- NHTC 0
- CTSO 2
- Target Price
- NHTC N/A
- CTSO $5.50
- AVG Volume (30 Days)
- NHTC 14.2K
- CTSO 136.2K
- Earning Date
- NHTC 07-30-2025
- CTSO 08-12-2025
- Dividend Yield
- NHTC 17.66%
- CTSO N/A
- EPS Growth
- NHTC N/A
- CTSO N/A
- EPS
- NHTC 0.04
- CTSO N/A
- Revenue
- NHTC $42,749,000.00
- CTSO $35,332,238.00
- Revenue This Year
- NHTC N/A
- CTSO $18.34
- Revenue Next Year
- NHTC N/A
- CTSO $19.82
- P/E Ratio
- NHTC $114.21
- CTSO N/A
- Revenue Growth
- NHTC N/A
- CTSO 15.37
- 52 Week Low
- NHTC $4.02
- CTSO $0.71
- 52 Week High
- NHTC $7.35
- CTSO $1.61
- Technical
- Relative Strength Index (RSI)
- NHTC 55.19
- CTSO 52.96
- Support Level
- NHTC $4.55
- CTSO $0.93
- Resistance Level
- NHTC $4.80
- CTSO $1.16
- Average True Range (ATR)
- NHTC 0.15
- CTSO 0.11
- MACD
- NHTC 0.04
- CTSO -0.02
- Stochastic Oscillator
- NHTC 79.25
- CTSO 45.77
About NHTC Natural Health Trends Corp.
Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home. Wellness products include targeted nutrition for joint health, antioxidant support, digestive health, heart health, and vision health. Herbal products include anti-aging and hydrating cleansers, creams, lotions, serums, and toners. Lifestyle products improve the overall quality of life and to support active, physical and healthy lifestyles. Home products are designed to create a clean and natural living environment for the home. It generates a majority of its revenue from Hong Kong and rest from China, Taiwan, Japan, United States and other regions.
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.